HDFC Life Insurance Q1 Results Highlights: Net Profit Iumps 15% on-year to ₹479 cr
Dabur India Q3 Results FY2023, PAT at Rs. 476.65 crores
Last Updated: 3rd February 2023 - 04:27 pm
On 2nd February, Dabur India announced its results for the third quarter of FY2023.
Key Highlights:
- Consolidated Revenue for the third quarter of 2022-23 stood at Rs. 3,043.17 crores.
- The net profit was reported at Rs. 476.65 crores with a 3-year CAGR at 6.1%.
Business Highlights:
- Dabur's Home care business ended the quarter with an 18.2% growth
- The Ayurvedic OTC business grew by 76.8% in Q3, while the Digestives category reported an 11.2% growth.
- Dabur's Food & Beverages business reported a 6.4% growth during the quarter, while the Toothpaste business, led by steady demand for the flagship Dabur Red paste, ended the quarter with a 32% growth.
- Dabur posted market share gains across the portfolio, led by a 250bps improvement in Juices & Nectars market share
- Dabur also reported a 70bps market share gain in Hair Oils to touch the highest-ever 16.2%.
- Dabur's share in the Chyawanprash category improved by 30bps.
- Dabur also reported a 40bps increase in Shampoo market share.
- Dabur's international Business reported a growth of 14% in Constant Currency terms, with a 3-Year CAGR of 14.1%. The Turkey business grew by 97%, while the Egypt business was up by 35%. The Sub-Saharan Africa business reported a growth of 17%, while the SAARC market grew by 8%
Commenting on the results, Dabur India Ltd Chief Executive Officer Mr. Mohit Malhotra said:
"We have delivered steady results in what continues to be a difficult cost and operating environment. We continued to adjust prices responsibly to reflect inflation, Our India business reported a growth of 3.3% with a 3-year CAGR of 9s% and steady market share gains across the portfolio, despite most operating categories reporting a decline."
Trending on 5paisa
05
Tanushree Jaiswal
Discover more of what matters to you.
Corporate Actions Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.